These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5982986)
41. Behavioral effects of methamphetamine and -methyltyrosine in the rat. Evans HL J Pharmacol Exp Ther; 1971 Jan; 176(1):244-54. PubMed ID: 5569634 [No Abstract] [Full Text] [Related]
42. Pharmacology of the central nervous system. Nelson SR; Walaszek EJ Prog Neurol Psychiatry; 1968; 23():134-54. PubMed ID: 4304825 [No Abstract] [Full Text] [Related]
43. Muricidal block produced by 5-hydroxytryptophan and various drugs. Kulkarni AS Life Sci; 1968 Feb; 7(3):125-8. PubMed ID: 5300261 [No Abstract] [Full Text] [Related]
44. [Effect of aziprine on the central nervous system]. Ponomareva AG Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457 [No Abstract] [Full Text] [Related]
45. State-dependent learning produced by depressant and atropine-like drugs. Overton DA Psychopharmacologia; 1966; 10(1):6-31. PubMed ID: 5982984 [No Abstract] [Full Text] [Related]
46. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine. Hymowitz N; Brezenoff HE Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084 [TBL] [Abstract][Full Text] [Related]
47. Similar action of imipramine and arginine-vasopressin in the social interaction test. Popik P; Vetulani J Pol J Pharmacol; 1993; 45(3):323-5. PubMed ID: 8220664 [TBL] [Abstract][Full Text] [Related]
48. The protective action of tocopherol and acetylsalicylic acid on the behavior of rats treated with dioxins. Rosińczuk J; Dymarek R; Całkosiński I Adv Clin Exp Med; 2018 Jan; 27(1):5-14. PubMed ID: 29521038 [TBL] [Abstract][Full Text] [Related]
49. Effects of DDT and of drug-DDT interactions on electroshock seizures in the rat. Woolley DE Toxicol Appl Pharmacol; 1970 Mar; 16(2):521-32. PubMed ID: 5435619 [No Abstract] [Full Text] [Related]
50. [EFFECTS OF IMIPRAMINE ON THE REACTION TO PAIN IN THE RAT]. CHARPENTIER J C R Seances Soc Biol Fil; 1963 Oct; 157():1002-5. PubMed ID: 14092077 [No Abstract] [Full Text] [Related]
51. Central nervous system effects of Sida retusa root. Joseph T; Shanthakumari G Jpn J Pharmacol; 1971 Feb; 21(1):136-8. PubMed ID: 5317247 [No Abstract] [Full Text] [Related]
52. The interaction of amphetamine and eserine on the EEG. Barnes CD Life Sci; 1966 Oct; 5(20):1897-902. PubMed ID: 5970097 [No Abstract] [Full Text] [Related]
53. Stereotypic and anticataleptic activities of amphetamine after intracerebral injections. Costall B; Naylor RJ; Olley JE Eur J Pharmacol; 1972 Apr; 18(1):83-94. PubMed ID: 5064045 [No Abstract] [Full Text] [Related]
54. The intracerebral effects of noradrenaline and its modification by drugs in the mouse. Brittain RT J Pharm Pharmacol; 1966 Sep; 18(9):621-3. PubMed ID: 4381949 [No Abstract] [Full Text] [Related]
55. Comparative behavioral effects of several anticholinergic agents in rats. Pradhan SN; Roth T Psychopharmacologia; 1968; 12(4):358-66. PubMed ID: 5652217 [No Abstract] [Full Text] [Related]
56. Effect of some antidepressive drugs on the blood pressure responses to the sympathomimetic amines. Apaatalo HI; Torsti P Ann Med Exp Biol Fenn; 1967; 45(4):309-402. PubMed ID: 5599048 [No Abstract] [Full Text] [Related]
57. Methodological problems in evaluating the role of cholinergic mechanisms in behavior. Weiss B; Heller A Fed Proc; 1969; 28(1):135-46. PubMed ID: 4974735 [No Abstract] [Full Text] [Related]
58. Modification of precipitated morphine withdrawal syndrome by drugs affecting cholinergic mechanisms. Jhamandas K; Sutak M; Bell S Eur J Pharmacol; 1973 Dec; 24(3):296-305. PubMed ID: 4148842 [No Abstract] [Full Text] [Related]
59. The central action of certain derivatives of butyrolactone. Pelczarska A Arch Immunol Ther Exp (Warsz); 1967; 15(2):271-89. PubMed ID: 6069909 [No Abstract] [Full Text] [Related]
60. [Methodical problems of psychopharmacology presented using the example of antidepressive agents]. Hoffmeister F Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]